FIELD: medicine, neurology. SUBSTANCE: method involves the usage of an aqueous solution of low-concentrated hydrogen peroxide as the main pharmacologically acting substance that is administration in common with pharmacological stabilizing agent. Administration is carried out by endonasal route by spraying, at least, two-fold injection into each nasal way with interval between aerosol doses for 10-15 s from 1 to 3 times per a day. Mannitol, benzoic acid, ethylenediaminetetraacetic acid disodium salt aqueous solutions are used as a stabilizing agent. EFFECT: enhanced effectiveness of curative effect. 3 cl, 2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| PARKINSON'S DISEASE TREATMENT MODE | 2007 |
|
RU2353382C1 |
| USING HEPTAPEPTIDE FOR TREATING PARKINSON'S DISEASE AND METHOD OF TREATING SUCH DISEASE | 2011 |
|
RU2450822C1 |
| METHOD OF REHABILITATION OF PATIENTS WITH PARKINSON'S DISEASE | 2010 |
|
RU2436557C1 |
| METHOD FOR DIAGNOSING CENTRAL VESTIBULAR DISORDERS CHARACTERISTIC OF THE EARLY STAGE OF PARKINSON'S DISEASE | 2017 |
|
RU2657963C1 |
| METHOD OF TREATING PARKINSONISM | 2008 |
|
RU2381818C2 |
| METHOD FOR PREDICTING DEVELOPMENT OF COGNITIVE DISORDERS IN PATIENTS WITH PARKINSON'S DISEASE | 2024 |
|
RU2828959C1 |
| METHOD FOR EARLY DIAGNOSIS OF PARKINSON'S DISEASE | 2019 |
|
RU2722666C1 |
| DIAGNOSTIC METHOD OF POSTURAL DISORDERS IN PARKINSON'S DISEASE | 2020 |
|
RU2733037C1 |
| METHOD FOR CARRYING OUT PARKINSON DISEASE PATIENTS AFTERCARE | 2006 |
|
RU2315632C1 |
| PHARMACEUTICAL COMPOSITION FOR TREATING PARKINSON'S DISEASE | 2008 |
|
RU2423981C2 |
Authors
Dates
2003-10-10—Published
2002-06-24—Filed